References
- Murphy, S., Rand, H., Rosenthal, D. and Lazio, J. (1986) "Essential thrombocythemia: an interim report from the Polycythemia Vera Study Group", Semin. Hematol. 23, 177.
- Pearson, T.C. (1991) "Primary thrombocythemia: diagnosis and management", Br. J. Haematol. 78, 145.
- Van Genderen, P.J.J. and Michiels, J.J. (1993) "Primary thrombocythaemia, diagnosis, clinical manifestations and management", Ann. Hematol. 67, 57.
- Singal, U., Prasad, AS., Halton, D.M. and Bishop, C. (1983) "Essential thrombocythemia: a clonal disorder of the hematopoietic stem cell", Am. J. Hematol. 14, 193.
- El-Kassar, N., Hetet, G., Briere, J. and Grandchamp, B. (1997) "Clonality analysis of hematopoiesis in essential thrombo-cythaemia, advantages of studying T lymphocytes and platelets", Blood 89, 28.
- Anger, B., Janssen, J.W.G., Schrezenmeier, H., Hehlmann, R., Heimpel, H. and Bartram, C.R. (1990) "Clonal analysis of chronic myeloproliferative disorders using X-linked DNA polymorphisms", Leukemia 4, 258.
- Murphy, S., Peterson, P., Iland, H. and Lazlo, J. (1997) "Experience of the Polycythemia Vera Study Group with essential thrombocythemia: a final report on diagnostic criteria, survival and leukemic transition by treatment", Semin. Hematol. 34, 29.
- Hoffman, R. (2000) "Primary Thrombocythemia", In: Hoffman, R., Benz, E., Shattil, S.J., Furie, B., Cohen, H.J., Silberstein, L.E. and McGlave, P., eds, Hematology, Basic Principles and Practice, 3rd Ed. (Churchill Livingstone, Philadelphia PA).
- Balduini, C.L. (1992) "Primary thrombocythemia: new drugs for an evolving disease", Haemostasis 77, 297.
- Frenkel, E.P. (1991) "Southwestern Internal Medicine Con-ference: The clinical spectrum of thrombocytosis and thrombocythemia", Am. J. Med. Sci. 301, 69.
- Van Genderen, P.J.J., Mulder, P.G.H., Waleboer, M., van de Moesdijk, D. and Michiels, J.J. (1997) "Prevention and treatment of thrombotic complications in essential thrombo-cythemia: efficacy and safety of aspirin", Br. J. Haematol. 97, 179.
- Lengfelder, E., Griesshammer, M. and Hehlmann, R. (1996) "Interferon-alpha in treatment of essential thrombocythe-mia", Leuk. Lymphoma 22, 135.
- Talpaz, M., Kurzrock, R., Kantarjian, H., O'Brien, S. and Gutterman, J.U. (1989) "Recombinant interferon-alpha therapy of Philadelphia chromosome negative myeloproli-ferative disorders with thrombocytosis", Am. J. Med. 86, 554.
- Tefferi, A., Elliot, M.A., Solberg, Jr., L.H. and Silverstein, M.N. (1997) "New drugs in essential thrombocythemia and polycythemia vera", Blood Rev. 11, 1.
- Silverstein, UN., Solberg, L.A., Silver, R.T., Fitch, T., Mazur, E., Allen, S., Cuttner, J., Frenkel, G., Cherng, N.C., Yovan, N., Grechko, J., Pettit, R.M., Rosenbloom, B., Knospe, W., Colon-Otero, G., Doyle, G., Gilbert, H.S., Weick, J., Miller, W., Burroughs, J., Khoory, M. and Schacter, L.P. (1992) "Anagre-lide, a therapy for thrombocythemic states: experience in 577 patients", Am. J. Med. 92, 69.
- Tefferi, A., Silverstein, MN., Pettit, R.M., Mesa, R.A. and Solberg, Jr., L.A. (1997) "Anagrelide as a new platelet-lowering agent in essential thrombocythemia: mechanism of action, efficacy, toxicity, current indications", Semin. Thromb. Hemost. 23, 379.
- Oertel, M.D. (1998) "Anagrelide, a selective thrombocytope-nic agent", Am. J. Health-System Pharm. 55, 1979.
- Mazur, EM., Rosmarin, A.G., Sohl, P.A., Newton, J.L. and Narendan, A. (1992) "Analysis of the mechanism of anagrelide-induced thrombocytopenia in humans", Blood 79, 1931.
- Laguna, M.S., Kornblihtt, L.I., Marta, R.F., Michiels, J.J. and Molinas, F.C. (2000) "Effectiveness of anagrelide in the treatment of symptomatic patients with essential thrombo-cythemia", Clin. Appl. Thromb. Hemost. 6, 157.